Ex-drug exec Shkreli's U.S. fraud trial set for June 2017

NEW YORK, July 14 (Reuters) - A federal judge on Thursday scheduled a trial for June 2017 in the U.S. government's securities fraud case against former pharmaceutical executive Martin Shkreli, who became a lightning rod last year for outrage over soaring prescription drug prices.